Tsukuba, Japan – Heavy snowfall slows things down and makes it harder to get from point A to point B. But snow clouds have a silver lining–heavy snow may prevent serious road injuries and even save lives. How? By getting people off bicycles and switching to safer modes of transport. Japanese researchers examined 10 years…
The ACTIV-3 clinical trial, which is evaluating the safety and efficacy of investigational therapeutics for COVID-19 in hospitalized patients, has closed enrollment in two sub-studies: one examining the investigational monoclonal antibody therapy VIR-7831, and another evaluating the investigational combination monoclonal antibody therapy containing BRII-196 and BRII-198. The sub-studies were halted by the trial sponsor, the…
New cutting-edge research undertaken at the University of Leicester could revolutionise the way new drugs are developed and the way patients are cared for, through a pioneering new approach using virtual clinical trials. Following a £500,000 Royal Academy of Engineering research funding award, Dr Himanshu Kaul, will expand research with his ‘virtual asthma patient’ to…
BUFFALO, N.Y. — It looks like science fiction: A machine dips into a shallow vat of translucent yellow goo and pulls out what becomes a life-sized hand. But the seven-second video, which is sped-up from 19 minutes, is real. The hand, which would take six hours to create using conventional 3D printing methods,…
Researchers from University of Houston and University of Bochum published a new paper in the Journal of Marketing that examines how variable compensation plans for salespeople can lead to lower health. The study, forthcoming in the Journal of Marketing, is titled “Variable Compensation and Salesperson Health” and is authored by Johannes Habel, Sascha Alavi, and…
Scientists at Walter Reed Army Institute of Research, in a collaboration with Duke University, have confirmed that monoclonal antibodies can be an effective tool in the global fight against malaria. The study, led by Dr. Sheetij Dutta, chief of the Structural Vaccinology Laboratory at WRAIR, showed that mAbs such as CIS43 were most…
The global population is aging, and so are their eyes. In fact, the number of people with vision impairment and blindness is expected to more than double over the next 30 years. A meta-analysis in The Lancet Global Health, consisting of 48,000 people from 17 studies, found that those with more severe vision impairment had…
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women’s Hospital and Harvard Medical School. The study suggests that gender disparities during the pandemic may signify not only…
Ivermectin, a controversial anti-parasitic drug that has been touted as a potential Covid-19 treatment, does not speed recovery in people with mild cases of the disease, according to a randomized controlled trial published on Thursday in the journal JAMA. Ivermectin is typically used to treat parasitic worms in both people and animals, but scientific evidence…
In North Dakota this week, health officials are sending their first Johnson & Johnson Covid-19 vaccines to pharmacies and urgent care clinics, where people who don’t necessarily have a regular doctor can get the single jab. In Missouri, doses are going to community health centers and rural hospitals. And in North Carolina, health providers are…